SCHEMBL4933359

SCHEMBL4933359

O=c1[nH]c2ccc(Cl)cc2n1-c1ccc(OCC(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
DAO P14920 1/20 0.44
AURKA O14965 1/20 0.43
MAOB P27338 6/20 0.42
PGR P06401 2/20 0.41
HRH3 Q9Y5N1 1/20 0.41
MAT2A P31153 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922001 0.91 MEN1 (0.59) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL4929661 0.87 HRH3 (0.43) MEN1LMNAKMT2AL3MBTL1MAOB
SCHEMBL4930459 0.84 L3MBTL1 (0.49) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL4933166 0.84 MEN1 (0.49) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL14463402 0.84 MAOB (0.42) MAOBPGRHRH3LIPE
SCHEMBL4931086 0.82 L3MBTL1 (0.47) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL4928761 0.82 L3MBTL1 (0.47) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL4930971 0.81 L3MBTL1 (0.46) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL11348908 0.80 LMNA (0.62) MEN1LMNAKMT2AL3MBTL1DAO
SCHEMBL4931135 0.80 GABRP (0.56) MEN1LMNAKMT2AL3MBTL1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 MEN1 4097/4885LMNA 4744/4885KMT2A 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.